Detalhe da pesquisa
1.
Lenvatinib plus pembrolizumab for systemic therapy-naïve and -experienced unresectable hepatocellular carcinoma.
Cancer Immunol Immunother
; 71(11): 2631-2643, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347395
2.
Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.
J Formos Med Assoc
; 119(1 Pt 1): 125-133, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30876788
3.
Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma.
Liver Cancer
; 13(1): 29-40, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38344446
4.
Analyzing risk factors and developing a stratification system for hepatocellular carcinoma recurrence after interferon-free direct-acting antiviral therapy in chronic hepatitis C patients.
J Chin Med Assoc
; 87(4): 357-368, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180018
5.
Determinants of Survival and Post-Progression Outcomes by Sorafenib-Regorafenib Sequencing for Unresectable Hepatocellular Carcinoma.
Cancers (Basel)
; 14(8)2022 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35454919
6.
Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma.
J Immunother Cancer
; 10(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35738801
7.
Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment.
Viruses
; 14(11)2022 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36366452
8.
Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan.
J Microbiol Immunol Infect
; 54(3): 385-395, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31771822
9.
Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria.
Liver Cancer
; 10(6): 629-640, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34950185
10.
Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection.
Cancers (Basel)
; 13(17)2021 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503135
11.
Comparable benefits of HCV eradication by direct acting antivirals and interferon-based therapy in patients with hepatocellular carcinoma undergoing surgical resection.
Am J Cancer Res
; 11(11): 5526-5542, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34873477